MDY News 246.22 05/22/2014 05:11:31 SPDR S&P Midcap 400 (MDY

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
SPDR S&P Midcap 400 (MDY) 246.22 $MDY

Midcap SPDR Trust Series 1 Rises 1.50% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 12, 4:01PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $247.40 to a high of $250.48. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $249.36 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Look for Shares of Midcap SPDR Trust Series 1 to Potentially Pullback after Yesterday's 1.50% Rise
Comtex SmarTrend(R) - Mon May 12, 4:00PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $247.40 to a high of $250.48. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $249.36 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

'Sell In May,' Other Red Flags Dooming Stock Market
at Investor's Business Daily - Tue May 06, 6:02PM CDT
Investors have more than just seasonal weakness to worry about in May as a handful of other red flags are weighing on the market. A sell-off in higher-growth, more economically sensitive stocks in April -- mainly small caps and technology -- coupled...

Jobs Report Weighs Heavy on Dems, GOP for Midterms
at The Street - Fri May 02, 1:49PM CDT
The jobs report is already influencing the midterm elections.

Investors Should Take Calm From the Latest Fed Statement
at The Street - Thu May 01, 4:00AM CDT
Investors received calming news from the latest Federal Reserve statement.

Midcap SPDR Trust Series 1 Set to Possibly Rebound After Yesterday's Selloff of 1.19%
Comtex SmarTrend(R) - Fri Apr 25, 4:16PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $244.69 to a high of $247.39. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $245.95 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Watch for Midcap SPDR Trust Series 1 to Potentially Rebound After Falling 1.19% Yesterday
Comtex SmarTrend(R) - Fri Apr 25, 4:15PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $244.69 to a high of $247.39. Yesterday, the shares fell 1.2%, which took the trading range below the 3-day low of $245.95 on volume of 1.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SPDR S&P MIDCAP 400 ETF Experiences Big Outflow
ETFChannel.com - Fri Apr 25, 10:11AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P MIDCAP 400 ETF where we have detected an approximate $43.4 million dollar outflow -- that's a 0.3%...

First Week of MDY December 20th Options Trading
DividendChannel.com - Tue Apr 22, 11:10AM CDT
Investors in SPDR S&P MidCap 400 ETF saw new options begin trading this week, for the December 20th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until...

Midcap SPDR Trust Series 1 Set to Possibly Pullback After Yesterday's Rally of 1.16%
Comtex SmarTrend(R) - Wed Apr 16, 4:45PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $243.14 to a high of $245.34. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $243.06 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

SmarTrend Watching for Potential Pullback in Shares of Midcap SPDR Trust Series 1 After 1.16% Gain
Comtex SmarTrend(R) - Wed Apr 16, 4:44PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $243.14 to a high of $245.34. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $243.06 on volume of 1.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Noteworthy ETF Outflows: MDY, AMG, XEC, HSIC
ETFChannel.com - Wed Apr 16, 9:49AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P MIDCAP 400 ETF where we have detected an approximate $375.9 million dollar outflow -- that's a 2.5%...

After Yesterday's Decline of 2.18%, Midcap SPDR Trust Series 1 Offers Investors Better Value
Comtex SmarTrend(R) - Thu Apr 10, 4:00PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $242.18 to a high of $248.23. Yesterday, the shares fell 2.2%, which took the trading range below the 3-day low of $243.00 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

SmarTrend Watching for Potential Rebound in Shares of Midcap SPDR Trust Series 1 After 1.53% Loss
Comtex SmarTrend(R) - Fri Apr 04, 3:50PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $247.94 to a high of $254.48. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $250.93 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of Midcap SPDR Trust Series 1 to Potentially Rebound after Yesterday's 1.53% Sell Off
Comtex SmarTrend(R) - Fri Apr 04, 3:50PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $247.94 to a high of $254.48. Yesterday, the shares fell 1.5%, which took the trading range below the 3-day low of $250.93 on volume of 2.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Midcap SPDR Trust Series 1 Falls 1.31% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Mar 26, 4:00PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $246.13 to a high of $251.07. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $247.38 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.31%, Midcap SPDR Trust Series 1 Offers Investors Better Value
Comtex SmarTrend(R) - Wed Mar 26, 3:59PM CDT
Midcap SPDR Trust Series 1 (AMEX:MDY) traded in a range yesterday that spanned from a low of $246.13 to a high of $251.07. Yesterday, the shares fell 1.3%, which took the trading range below the 3-day low of $247.38 on volume of 1.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

MDY, GMCR, HSIC, TRMB: Large Inflows Detected at ETF
ETFChannel.com - Fri Mar 21, 10:04AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P MidCap 400 ETF where we have detected an approximate $94.4 million dollar inflow -- that's a 0.6% increase...
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 0

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 206

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 0

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 64

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 50

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 208

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 79

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 287

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
LexisNexis Debuts AI-Guided Field Clarity at IACP 2026

Updated Category News Views 7

LexisNexis Takes a Serious Step Forward The world of law enforcement reporting just got a shake-up. LexisNexis Coplogic Solutions launched a souped-up version of its Desk Officer Reporting System (DORS) at the IACP 2026 event. They paired DORS with Field Clarity, a newfangled AI-powered assistant that aims to make police reporting slicker and more accurate. You can bet...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 124

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Cat Holdings Faces Class Action Lawsuit from Investors

Updated Category News Views 209

Overview of the Class Action Against Red Cat Holdings Pomerantz LLP has announced that a class action lawsuit has been initiated against Red Cat Holdings, Inc. (RCAT) and certain officers due to allegations of misconduct. The legal action is filed in the United States District Court for the District of New Jersey. This lawsuit represents a class of individuals or entities...

Continue Reading
IPVanish: The Ultimate Solution for Cloud Storage Security

Updated Category News Views 129

IPVanish: Leading the Charge in Cloud Security As more individuals and businesses migrate to the cloud, the urgency for secure storage solutions has skyrocketed. IPVanish has stepped up to become a standout player in this landscape, recognized for its outstanding cloud access tools and strong privacy measures. Transformation into a Comprehensive Security Platform...

Continue Reading
Runway Growth Capital Bolsters Leadership with Rovner

Updated Category News Views 11

A New Era for Runway Growth Capital Alright folks, here's the scoop for anyone tracking the moves in the growth lending space: Michael Rovner, with his hefty 30-year career in the financial sector, is now taking on the role of Co-Chief Executive Officer and Co-Chief Investment Officer at Runway Growth Capital. This guy's a veteran, no doubt, having navigated the overlaps...

Continue Reading
Investors Anticipate Earnings from Booz Allen Hamilton Soon

Updated Category News Views 134

Market Expectations for Booz Allen Hamilton's Earnings Booz Allen Hamilton (NYSE: BAH) is set to unveil its quarterly earnings soon, and it's important for investors to be well-prepared. Analysts anticipate an earnings per share (EPS) of $1.51, a key figure to watch as it could impact stock sentiment significantly. Performance Insights and Analyst Predictions The hope...

Continue Reading
USD/JPY Holds Steady Amid Economic Shifts and Data Releases

Updated Category News Views 124

USD/JPY Stabilizes After Inflation Adjustments The USD/JPY currency pair has recently stabilized after a brief drop below the key level of 141.77. This dip happened just before the US Consumer Price Index (CPI) was announced, revealing an inflation rate of 2.5%. Following this data release, the currency pair started to rebound, thanks in part to a slight increase in US...

Continue Reading